Stifel Financial Corp Takeda Pharmaceutical CO LTD Transaction History
Stifel Financial Corp
- $106 Billion
- Q3 2025
A detailed history of Stifel Financial Corp transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Stifel Financial Corp holds 508,924 shares of TAK stock, worth $7.27 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
508,924
Previous 454,019
12.09%
Holding current value
$7.27 Million
Previous $7.02 Million
6.14%
% of portfolio
0.01%
Previous 0.01%
Shares
28 transactions
Others Institutions Holding TAK
# of Institutions
384Shares Held
80.7MCall Options Held
1.67MPut Options Held
276K-
Capital Research Global Investors Los Angeles, CA13.4MShares$192 Million0.04% of portfolio
-
Morgan Stanley New York, NY7.69MShares$110 Million0.01% of portfolio
-
Ubs Group Ag5.89MShares$84.2 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.95MShares$70.8 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.93MShares$56.2 Million0.48% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $44.4B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...